Jarsa Gumba Forte

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.11.003.Е.001350.03.16
Date of registration and renewal:25.03.2016
Dosage form: & nbspa tablet weighing 1.5 grams
Classification "Composition" & nbsp BAD - products of plant, animal or mineral origin
Classification "Clinical" & nbsp Supplements of restorative and tonic effect for men and women
Composition: & nbspThe content of biologically active substances, mg / tab., Not less: taurine - 95,0, flavonoids in terms of routine - 8,5, proanthocyanidins - 55,0, panaxosides - 3,5, eleuterosides - 0,8, yohimbine - 2 , 1 - (no more than 2.5), icarian - 30.0, arginine - qualitative identification.

extracts of epimedium, long-leaf eurycoma, ginseng roots, eleutherococcus, Chinese cordyceps, dwarf pine, ginkgo biloba, yohimbe bark, pepper, L-arginine alpha-ketoglutarate, L-taurine, E460, lactose monohydrate, E470, E143.
Scope: & nbspfor realization to the population as a biologically active additive to food - a source of taurine, flavonoids, eleutherosides, panaxosides, proanthocyanidins containing ikariin, yohimbine.
Suggested Usage: & nbspadult men 1 tablet a day with meals. Duration of admission is 2-3 weeks. Repeated reception is possible after 1-2 months. Repeated receptions are possible throughout the year.
Contraindications:individual intolerance of components, severe liver and kidney disease, cardiovascular diseases, in the treatment of adrenomimetics, high blood pressure,violation of the rhythm of cardiac activity, pronounced atherosclerosis, insomnia, reception in the evening, increased nervous excitability. Before use, it is recommended to consult a doctor.
Shelf life:36 months.
Storage conditions:Keep in a dry place, protected from direct sunlight and out of the reach of children, at a temperature not exceeding 25 ° C.
Research protocols:expert conclusion of the FBUC of the Federal Target Program and the Federal Service for Consumer Rights Protection No. 10-2FTS / 4130 of 15.10.2015.
Recipient:Pharmaceutical holding GI EL Medical, OOOPharmaceutical holding GI EL Medical, OOO Russian Federation
Information update date: & nbsp05.04.2016
Instructions
Up
talkdrugs

+8 (800)555-35-35

[email protected]

The reference book of medicines of the Publishing Group "GEOTAR-Media" - the leader in the field of professional medical and pharmaceutical literature.

The information on the preparations placed on the site is intended only for specialists.Drug descriptions can not be used by patients to make an independent decision on their use.

It is forbidden to copy any instructions of medicinal products, biologically active additives or other information from the site www.talkdrugs.info without the written permission of the Publishing House "GEOTAR".

All rights reserved. © Publishing group "GEOTAR-Media" 2008-2016.